
Emerging SME Services · NSE
Established in 2019, Maitreya Medicare Limited is a multispeciality hospital located in Surat, Gujarat, offering integrated healthcare services across primary, secondary, and tertiary care. The hospital provides treatment in over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Neurosurgery, Neurology, Gastroenterology, Orthopedic Surgery, Critical Care Medicine, and more. As of 2023, Maitreya Medicare has a 125-bed capacity and is led by Dr. Narendra Singh Tanwar (Founder, Promoter, CFO & Managing Director), Dr. Pranav Rohitbhai Thaker (Promoter & Whole-time Director), and Mr. Vimal Patel (Promoter & Whole-time Director). The hospital is committed to providing high-quality, multidisciplinary healthcare services to patients.
Price Band
₹78 – ₹82
Issue Size
₹14.89 Cr
Lot Size
1600 shares
GMP
+91.5%
Est. Listing
₹157
at current GMP
Subscribed
446.88x
overall
Open
27 Oct 2023
Close
1 Nov 2023
Allotment
3 Nov 2023
Refund
4 Nov 2023
Demat Credit
5 Nov 2023
Listing
7 Nov 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹82
Band: ₹78 – ₹82
Estimated Listing Price
₹157
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,31,200
Estimated Profit / Lot
₹1,20,000
1600 × ₹75
Grey Market Premium trend
+₹75
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹75 | 91.5% | ₹157 |
| 30 Oct 2026 | +₹75 | 91.5% | ₹157 |
| 29 Oct 2026 | +₹68 | 82.3% | ₹150 |
GMP is unofficial market data. Not a guarantee of listing performance.
Maitreya Medicare Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹14.89 Crores. The shares are offered at a price band of ₹78 to ₹82 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2023-11-01, the basis of allotment is scheduled to be finalized on 2023-11-03. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Ltd) or the BSE allotment checking window.
The latest grey market premium for Maitreya Medicare Limited IPO is ₹75, which indicates an expected listing price of ₹157.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.